ELI LILLY & CO (LLY)
Clinical trial NCT07589608 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-15
Clinical trial NCT07589608 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-15
Clinical trial NCT07174726: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07660198 updates: 1. start date: 2026-06-17 → 2026-06-15 2. completion date: 2027-12-04 → 2027-12-02 3. primary completion date: 2027-12-04 → 2027-12-02
Clinical trial NCT04089579: intervention model: CROSSOVER → PARALLEL.
Clinical trial NCT03651076: enrollment: 141 → 142 participants.
Clinical trial NCT06283966: enrollment: 5000 → 5250 participants.
Clinical trial NCT04954859 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-02-08 → 2029-01-24 3. primary completion date: 2029-02-08 → 2029-01-24 4. enrollment: 450 → 360 participants
Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17
Clinical trial NCT07571200 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-14
Clinical trial NCT04205812 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-28 → 2026-05-28